Factors contributing to cerebral hypomyelination in the growth hormone-deficient little mouse.
We attempted to delineate the events leading to hypomyelination in the brain of the little mouse, a promising murine model of isolated growth hormone deficiency. At 20 days of age, the mutant mouse brain weighed less than its normal counterpart, and this difference in brain weight persisted. Increase in CNPase activity was found to be suppressed in the cerebrum throughout the developmental stage, but not in the other parts of the brain. Differences in cerebral DNA content between the little and normal mice first became apparent on the 10th day of age. Thereafter, the rate of increase in the little brain consistently lagged behind the normal. [3H]Thymidine incorporation into the DNA fraction in vivo on the 7th day of age, when glial cell proliferation in the normal cerebrum is most active, was approximately half that of the controls in all parts of the little brain. These findings indicate that the hypomyelination of the mutant cerebrum might result from reduced oligodendroglial proliferation due to growth hormone deficiency.
Morisawa
K
K
Department of Physiology, Toho University School of Medicine, Tokyo, Japan.
Sugisaki
T
T
Kanamatsu
T
T
Aoki
T
T
Noguchi
T
T
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000378:metabolism; D000375:Aging; D000818:Animals; D001921:Brain / Q000254:growth & development / Q000378:metabolism / Q000473:pathology*; D004247:DNA / Q000032:analysis; D004261:DNA Replication; D005260:Female; D013006:Growth Hormone / Q000172:deficiency*; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009154:Mutation; D009186:Myelin Sheath / Q000502:physiology*
D013006:Growth Hormone; D004247:DNA; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases